Nebu Koshy
Overview
Explore the profile of Nebu Koshy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gyurkocza B, Nath R, Seropian S, Choe H, Litzow M, Abboud C, et al.
J Clin Oncol
. 2024 Sep;
43(2):201-213.
PMID: 39298738
Purpose: Older patients with relapsed or refractory AML (RR AML) have dismal prognoses without allogeneic hematopoietic cell transplantation (alloHCT). SIERRA compared a targeted pretransplant regimen involving the anti-CD45 radioconjugate I-apamistamab...
2.
Master S, Koshy N, Mansour R, Shi R
Anticancer Res
. 2019 Apr;
39(4):1899-1906.
PMID: 30952731
Background: A retrospective analysis was performed to investigate the survival outcomes in adult acute lymphoblastic leukemia (ALL) based on treatment received. Materials And Methods: Data from 17,504 men and women...
3.
Joel Chandranesan A, Master S, Antosz O, PeytonThomas B, Koshy N
Case Rep Hematol
. 2018 Jun;
2018:2849869.
PMID: 29854497
Rhabdomyolysis is a life-threatening syndrome due to breakdown of the skeletal muscle. It can be caused by massive trauma and crush injuries or occur as a side effect of medications....
4.
Master S, Dwary A, Mansour R, Mills G, Koshy N
Case Rep Oncol
. 2018 Apr;
11(1):191-195.
PMID: 29681820
Eltrombopag is a thrombopoietin agonist and has been used in aplastic anemia and post-transplantation thrombocytopenia. The c-MPL receptor is present on hematopoietic stem cells. There are no reports of eltrombopag...
5.
Dwary A, Master S, Patel A, Cole C, Mansour R, Mills G, et al.
Oncotarget
. 2017 Dec;
8(53):91795-91802.
PMID: 29207685
Introduction: Immunotherapy in the form of immune checkpoint inhibitors has changed the landscape of cancer treatment. Newer monoclonal antibodies are coming up and are being tested in various cancers during...
6.
Master S, Leary C, Takalkar A, Coltelingam J, Mansour R, Mills G, et al.
Case Rep Oncol
. 2017 Jul;
10(2):534-541.
PMID: 28690529
Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports...
7.
Master S, Koshy N, Wilkinson B, Rosen L, Mills G, Mansour R, et al.
Anticancer Res
. 2017 May;
37(6):3035-3043.
PMID: 28551642
Background/aim: Hodgkin's Lymphoma (HL) is curable in up to 80% of patients due, in part, to simultaneous advances in chemotherapy regimens as well as radiation therapy planning and delivery. Concerns...
8.
Cingam S, Koshy N, Veillon D, Peddi P
BMJ Case Rep
. 2017 Mar;
2017.
PMID: 28275019
Severe vitamin B deficiency is well known to cause morphological alterations in bone marrow. In rare instances, these myelodysplastic and megaloblastic changes can coexist with cytogenetic abnormalities. Here, we report...
9.
Van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, et al.
Leuk Lymphoma
. 2016 Oct;
58(6):1512-1514.
PMID: 27786572
No abstract available.
10.
Van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, et al.
Leuk Lymphoma
. 2016 Jun;
58(2):288-297.
PMID: 27333804
Haplo-cord stem cell transplantation combines the infusion of CD34 selected hematopoietic progenitors from a haplo-identical donor with an umbilical cord blood (UCB) graft from an unrelated donor and allows faster...